The purpose of this project is to improve the existing version of the Sequential Alignment and Position Verification System (SAPVS) for functional proton radiosurgery and to evaluate its performance after improvement .

The Leksell Gamma Knife® is an instrument designed for high precision treatment of tumours and lesions located in the brain and upper spine. Today, the radioactive cobalt-60 sources can only move linearly along the radiation unit, but the machine could be modified to include rotational motion as well. We extend an existing linear programming approach to inverse planning for the Gamma Knife by examining the benefits from rotational degrees of freedom. The improvements offered from rotations are limited, but easy to make use of. We investigate the model in four patient cases, and find that an upper bound on the improvement of the optimization cost function is between 4.5% and 7.0% depending on case. With a total of four angles distributed uniformly over a 45 degree interval, one can in each case achieve a solution that performs up to within 1% of this bound. The average maximal improvements in terms of clinical metrics are 0.5% selectivity and 1.9% gradient index, at the cost of 5.9% worse beam-on time. No statistically significant change in coverage is found. A dynamic model based on column generation is proposed, which allows treatment during constant velocity angular motion and can achieve practically the same plan quality as the model with uniformly distributed angles at a significantly lower problem size. A similar algorithm can be designed to locate the most effective angles in a non-uniform manner that achieves better plans with fewer added rotational degrees of freedom. Trade-offs between memory and solution times are used to successively reduce the RAM occupation by around 90% and make significantly larger models computationally feasible to solve. A voxel clustering approach with emphasis on surface voxels, adapted to the radiosurgical framework, can significantly reduce the problem size while still producing competitive plans. / Strålkniven Leksell Gamma Knife® är ett instrument designat för högprecisionsbestrålning av tumörer och lesioner i hjärnan och övre delen av ryggraden. Idag kan de radioaktiva källorna endast förflyttas linjärt under behandlingen, men maskinen skulle kunna modifieras för att även tillåta rotationsrörelser. Vi utvidgar ett ramverk för inversplanering, formulerat som ett linjär-programmeringsproblem, genom att undersöka fördelarna med nya rotationsfrihetsgrader. Förbättringarna som rotationer möjliggör är begränsade, men kan relativt enkelt tas till vara. Vi undersöker de potentiella förändringarna i fyra patientfall och finner att den övre gränsen av förbättringarna för målfunktionsvärdet i optimeringsproblemet är mellan 4.5% och 7.0% beroende på fall. Genom att tillåta rotation av källorna till fyra jämnt fördelade vinklar över 45 grader kan man i samtliga fall hitta en lösning som är inom 1% från det bästa målfunktionsvärdet. De genomsnittliga förbättringarna i form av kliniska metriker är 0.5% selektivitet och 1.9% gradient-index, dock på bekostnad av en försämring av bestrålningstiden med 5.9%. Ingen tydlig förändring av täckningen kunde påvisas. En modell baserad på kolumngenerering, som tillåter behandling under rotation av kollimator-kroppen med konstant hastighet, föreslås. I denna modell kan praktiskt taget lika bra lösningar uppnås som för likformigt fördelade vinklar, men med betydligt mindre problemstorlek. En liknande algoritm kan lokalisera de mest effektiva vinklarna och åstadkomma samma plankvalitet med färre, men olikformt fördelade, rotationsfrihetsgrader. RAM-användningen kan reduceras med cirka 90% genom avvägningar mellan minne och beräknings-tider, vilket möjliggör lösning av probleminstanser som tidigare var beräkningsmässigt omöjliga. Klustringsmetoder av voxlar anpassade till strålkniven kan minska problemstorleken betydelsefullt medan de resulterande behandlingsplanerna är fortsatt konkurrenskraftiga.

Le Cyberknife (Accuray, Sunnyvale, CA) est un appareil de radiochirurgie stéréotaxique sans cadre. Il a été développé pour administrer de fortes doses dans des volumes restreints. Aussi, pour obtenir une conformation optimale de traitement, des champs circulaires de petites dimensions sont utilisés (\phi = 0,5 à 6 cm). L'étude dosimétrique de ces petits champs doit être menée selon de nouveaux standards puisque ceux-ci échappent aux définitions du TG-51. L'objectif de ce projet est d'implanter une plateforme de calcul de dose de type Monte Carlo pour le CyberKnife en clinique. Il s'articule autour de deux réalisations principales. Tout d'abord, une caractérisation dosimétrique du modèle Monte Carlo de l'accélérateur linéaire du CyberKnife a été menée à travers des simulations Monte Carlo générées par le moteur de EGSnrc. Cette étude est basée sur la caractérisation de la réponse d'un détecteur à un champ de type CK à partir de simulations EGS_chamber. Cette approche permet de prendre en compte l'impact du détecteur sur les mesures expérimentales. Cet aspect est d'autant plus important que le modèle Monte Carlo de l'accélérateur est validé à partir de mesures expérimentales. Les résultats obtenus montrent une bonne concordance, <1% ou 1 mm, entre les mesures expérimentales et les données de simulations pour les grands champs. Pour les champs de diamètre < 12,5 mm, le modèle est moins exact et une correction est appliquée pour atteindre une différence de <1% ou 1 mm. Deuxièmement, ce modèle validé du CK a été implanté dans un cadre de calcul Monte Carlo complet. Une plateforme de calcul dédiée aux calculs Monte Carlo, WebTPS, a été adaptée aux calculs de dose CK. Cette plateforme reçoit les données relatives au plan de traitement et lance des calcul EGSnrc sur un superordinateur. Cette approche tend à réduire les approximations lors de l'évaluation dosimétrique de plans de traitements cliniques. Une incertitude inférieure à 1% peut être atteinte en deux heures de calcul. Ce projet a donc pour objectif de développer une référence clinique pour le calcul de dose dans le cadre de la radiochirurgie stéréotaxique. L'outil WebTPS pourrait être particulièrement utile en clinique, l'algorithme de calcul de dose du CK étant limité dans plusieurs situations de traitement. / Purpose: The scope of this study is to implement a clinical Monte Carlo dose calculation system based on the EGSnrc engine. This web-based tool will be mostly used to evaluate clinical treatment plans in highly heterogeneous phantoms. Methods: The Monte Carlo calculation tool is based on the DOSXYZnrc user code. The platform automatically converts CyberKnife clinical plan to the user code input files. Phantoms can be created from HU to ED curves or by manually assigning material using medical contours. Parallel computation is made on a Compute Canada high-performance cluster to reduce simulation time. A Monte Carlo CyberKnife model is built on BEAMnrc user code using the manufacturer specifications. Simulated and experimental data is compared to estimate the electron beam parameters. The beam energy estimation is based on percent depth dose (PDD) comparison while the full width at half max (FWHM) is validated by output factor (OF) and off-axis ratio (OAR). An EGS_chamber model of the PTW60012 diode is used in the OF calculation. A set of phase-spaces is generated from the optimal model and for each collimator to calculate dose contribution from each incident beam. Results: The linac model optimisation yielded a 0.5% PDD agreement between experimental and simulation data, and a 0.5% or 1 mm for OAR. DOSxyz simulation of full treatment plan, based on the preliminary CyberKnife model, were achieved. Total Monte Carlo dose calculation have been achieved for heterogeneous phantoms. Uncertainty under 1% can be achieved for less than 2 hour of computing time. However, computing time estimation is nontrivial due to its dependence on cluster availability. Conclusion: This work aims to develop a suitable tool for reference plan dose calculation. This web-based tool would be used in several clinical and research applications where the CyberKnife embedded ray-tracing algorithm would show significant limitations. Because it is destined to a clinical use, the whole dose calculation system will be rigorously validated. / Le travail de modélisation a été réalisé à travers EGSnrc, un logiciel développé par le Conseil National de Recherche Canada.

Le travail de modélisation a été réalisé à travers EGSnrc, un logiciel développé par le Conseil National de Recherche Canada. / Le Cyberknife (Accuray, Sunnyvale, CA) est un appareil de radiochirurgie stéréotaxique sans cadre. Il a été développé pour administrer de fortes doses dans des volumes restreints. Aussi, pour obtenir une conformation optimale de traitement, des champs circulaires de petites dimensions sont utilisés (\phi = 0,5 à 6 cm). L'étude dosimétrique de ces petits champs doit être menée selon de nouveaux standards puisque ceux-ci échappent aux définitions du TG-51. L'objectif de ce projet est d'implanter une plateforme de calcul de dose de type Monte Carlo pour le CyberKnife en clinique. Il s'articule autour de deux réalisations principales. Tout d'abord, une caractérisation dosimétrique du modèle Monte Carlo de l'accélérateur linéaire du CyberKnife a été menée à travers des simulations Monte Carlo générées par le moteur de EGSnrc. Cette étude est basée sur la caractérisation de la réponse d'un détecteur à un champ de type CK à partir de simulations EGS_chamber. Cette approche permet de prendre en compte l'impact du détecteur sur les mesures expérimentales. Cet aspect est d'autant plus important que le modèle Monte Carlo de l'accélérateur est validé à partir de mesures expérimentales. Les résultats obtenus montrent une bonne concordance, <1% ou 1 mm, entre les mesures expérimentales et les données de simulations pour les grands champs. Pour les champs de diamètre < 12,5 mm, le modèle est moins exact et une correction est appliquée pour atteindre une différence de <1% ou 1 mm. Deuxièmement, ce modèle validé du CK a été implanté dans un cadre de calcul Monte Carlo complet. Une plateforme de calcul dédiée aux calculs Monte Carlo, WebTPS, a été adaptée aux calculs de dose CK. Cette plateforme reçoit les données relatives au plan de traitement et lance des calcul EGSnrc sur un superordinateur. Cette approche tend à réduire les approximations lors de l'évaluation dosimétrique de plans de traitements cliniques. Une incertitude inférieure à 1% peut être atteinte en deux heures de calcul. Ce projet a donc pour objectif de développer une référence clinique pour le calcul de dose dans le cadre de la radiochirurgie stéréotaxique. L'outil WebTPS pourrait être particulièrement utile en clinique, l'algorithme de calcul de dose du CK étant limité dans plusieurs situations de traitement. / Purpose: The scope of this study is to implement a clinical Monte Carlo dose calculation system based on the EGSnrc engine. This web-based tool will be mostly used to evaluate clinical treatment plans in highly heterogeneous phantoms. Methods: The Monte Carlo calculation tool is based on the DOSXYZnrc user code. The platform automatically converts CyberKnife clinical plan to the user code input files. Phantoms can be created from HU to ED curves or by manually assigning material using medical contours. Parallel computation is made on a Compute Canada high-performance cluster to reduce simulation time. A Monte Carlo CyberKnife model is built on BEAMnrc user code using the manufacturer specifications. Simulated and experimental data is compared to estimate the electron beam parameters. The beam energy estimation is based on percent depth dose (PDD) comparison while the full width at half max (FWHM) is validated by output factor (OF) and off-axis ratio (OAR). An EGS_chamber model of the PTW60012 diode is used in the OF calculation. A set of phase-spaces is generated from the optimal model and for each collimator to calculate dose contribution from each incident beam. Results: The linac model optimisation yielded a 0.5% PDD agreement between experimental and simulation data, and a 0.5% or 1 mm for OAR. DOSxyz simulation of full treatment plan, based on the preliminary CyberKnife model, were achieved. Total Monte Carlo dose calculation have been achieved for heterogeneous phantoms. Uncertainty under 1% can be achieved for less than 2 hour of computing time. However, computing time estimation is nontrivial due to its dependence on cluster availability. Conclusion: This work aims to develop a suitable tool for reference plan dose calculation. This web-based tool would be used in several clinical and research applications where the CyberKnife embedded ray-tracing algorithm would show significant limitations. Because it is destined to a clinical use, the whole dose calculation system will be rigorously validated.

CONTEXTO E OBJETIVO: O manejo do carcinoma hepatocelular (HCC) é desafiador devido a agressividade tumoral e cirrose associada. Faltam opções locais efetivas após falha à quimioembolização transarterial (TACE). Nosso objetivo foi testar através de estudo prospectivo fase II, a eficácia e segurança da Radioterapia Estereotáctica Corpórea (SBRT) em pacientes com HCC e resposta parcial ou contraindicação à TACE. MÉTODO: Pacientes com até 5 lesões de HCC restritas ao fígado realizaram SBRT na dose de 30 a 50 Gy em 5 frações. O desfecho primário foi sobrevida livre de progressão das lesões tratadas. Os desfechos secundários foram sobrevida livre de progressão hepática, sobrevida livre de progressão a distância, sobrevida global e toxicidade. Este estudo está registrado em clinicaltrials.gov sob o número NCT02221778. RESULTADO: De novembro de 2014 a junho de 2018, 19 pacientes receberam SBRT na dose mediana de 40 Gy (range 30 - 50 Gy). Todos tinham escore de Child Pugh A. A idade mediana foi de 67 anos (range 42-84 anos). A doença de base foi hepatite C em 42%, hepatite B em 26% e álcool em 26%. TACE prévia foi realizada em 84% dos pacientes, com mediana de duas TACEs (range 0-5). O número mediano de lesões foi dois (range 1-4), com tamanho mediano de 4 cm (1,5-10 cm). 32% dos pacientes tinham trombose tumoral; a AFP mediana pré-tratamento foi de 142,5 ng/ml (range 4,2 - 5 494 ng/ml). A sobrevida livre de progressão local em 1 ano foi de 80% (IC95%, 50% a 93%). A sobrevida livre de progressão hepática, sobrevida livre de progressão a distância e sobrevida global em 1 ano foram, respectivamente, de 52%, 82% e 84%. Não houve toxicidades clínicas grau 3 ou 4. Toxicidades laboratoriais até grau 3 ocorreram em 3 pacientes (16%). Resposta radiológica completa foi atingida em 53% dos pacientes, 42% tiveram resposta parcial. O tempo mediano para melhor resposta foi de 3,4 meses (range 2,4-12,6 meses). CONCLUSÃO: A SBRT é uma opção eficaz, segura e não invasiva em pacientes com HCC e resposta parcial ou contraindicação à quimioembolização / BACKGROUND AND PURPOUSE: Management of hepatocellular carcinoma (HCC) is challenging due to tumor aggressiveness and associated cirrhosis. There is paucity of effective local options after failure of transarterial chemoembolization (TACE). Our objective was to test in the setting of a phase II prospective study, the efficacy and safety of Stereotactic Body Radiation Therapy (SBRT) in patients with partial response or unsuitable for TACE. METHODS: Patients with HCC and up to five liver-only lesions received SBRT 30 to 50 Gy in 5 fractions. Primary endpoint was local progression-free survival. Secondary endpoints were liver progression-free survival, distant progression-free survival, overall survival and toxicity. This study is registered at clinicaltrials.gov NCT02221778. RESULTS: From Nov 2014 through Jun 2018, 19 patients received SBRT with a median dose of 40Gy (range 30 - 50 Gy). All patients were Child Pugh A. Median age was 67 years old (range 42-84y). Underlying liver disease was hepatitis C in 42% of patients, hepatitis B in 26% and alcohol-related in 26%. 84% received previous TACE, with a median of two TACEs (range 0-5). Patients had a median of two lesions (range 1-4), with median size of 4 cm (1.5-10 cm). 32% had tumor vascular thrombosis; median pretreatment AFP was 142.5 ng/ml (range 4.2 - 5,494 ng/ml). 1y local progression-free survival was 80% (95% CI, 50% to 93%). 1y liver progression-free survival, distant progression-free survival and overall survival were, respectively, 52%, 82% and 84%. No patient had clinical grade 3 or 4 toxicities. Laboratory toxicities up to grade 3 occurred in three patients (16%). Complete radiological response was seen in 53% of patients, 42% had partial response. Median time for best response was 3.4 months (range 2.4-12.6 months). CONCLUSION: SBRT is an effective, safe and noninvasive option in HCC patients with partial response or unsuitable for TACE

INTRODUÇÃO: Na Radioterapia, a acurácia da distribuição de dose em cálculos com correção de heterogeneidade está diretamente relacionada à escolha do algoritmo de cálculo. Existe uma variedade de algoritmos de cálculo disponíveis no mercado, variando em tempo de processamento e acurácia. Este estudo teve como objetivos quantificar a acurácia de dez diferentes algoritmos de cálculo em objetos simuladores de pulmão e analisar o impacto da escolha do algoritmo na distribuição de dose em radioterapia aplicada a tumores de pulmão. METODOLOGIA: Foram utilizados placas simuladoras de água (água sólida RW3) e pulmão (cortiça) para determinar a Porcentagem de Dose em Profundidade (PDP) e perfil transversal dentro da heterogeneidade (cortiça). As medidas foram realizadas em um Clinac Varian 6EX, com feixes de fótons de 6 MV e dois tamanhos de campo (5 x 5 cm2 e 10 x 10 cm2), irradiando-se filmes radiocrômicos Gafchromic EBT3 e câmara de ionização Scanditronix Wellhofer CC13. Planejamentos de 25 pacientes - 11 com técnica tridimendional (3D) e 14 com técnica de Radioterapia Estereotática Corpórea (SBRT) - foram realizados, inicialmente sem correção de heterogeneidade e, mantendo-se as UM, os cálculos com os diferentes algoritmos/métodos de correção foram comparados com o planejamento inicial. Foram avaliados as doses no volume alvo e nos órgãos em risco. RESULTADOS: As medidas realizadas em objetos simuladores revelaram que os algoritmos baseados no princípio da convolução (Eclipse® Pencil Beam Convolution com métodos de correção Batho, Batho Modificado e TAR equivalente; XiO® Clarkson e Convolution e iPlan® Pencil Beam) apresentaram diferenças de dose significativas na região da cortiça, sempre superestimando a medida, com uma sobredose superior a 8%. Algoritmos mais avançados, como o Eclipse® AAA e Acuros XB, XiO® Superposition e iPlan® XVMC, apresentaram desvios inferiores a 3% na região da heterogeneidade. A análise dos perfis mostra, igualmente, que a segunda classe de algoritmos apresenta melhor comportamento em meios de baixa densidade como a cortiça. A largura da penumbra apresentou desvios inferiores a 1 mm para os algoritmos mais avançados contra diferenças de até 4,5 mm entre os algoritmos baseados em convolução. A análise da distribuição de dose em planejamentos de tumores pulmonares mostrou que todos os cálculos com correção de heterogeneidade presentam doses superiores ao cálculo sem correção de heterogeneidade. O histograma dose-volume (DVH) do volume alvo sofreu um impacto maior do que dos órgãos em risco. Os cálculos realizados com algoritmos baseados em convolução apresentaram distribuições de dose semelhantes entre si, porém diferentes das do cálculo sem correção de heterogeneidade. Eclipse® AAA, Acuros XB, XiO® Superposition e iPlan® XVMC apresentaram distribuições de dose também semelhantes, porém Eclipse® Acuros XB e iPlan® XVMC são ainda mais similares. Os planejamentos de SBRT apresentaram resultados mais discrepantes do cálculo sem correção de heterogeneidade do que os planejamentos 3D. CONCLUSÕES: Os diferentes algoritmos de cálculo disponíveis possuem acurácias diferentes em meios de baixa densidade eletrônica. Essas diferenças possuem impacto nas distribuições de dose em planejamentos de tratamento de tumores pulmonares, sendo o impacto ainda maior para a técnica de SBRT. Entre os algoritmos avaliados, há pelo menos um de cada fabricante que apresentou bom desempenho em objetos simuladores de pulmão e que devem ser priorizados para o cálculo em planejamentos de tratamentos de câncer de pulmão / INTRODUCTION: In Radiotherapy, the dose distribution accuracy in heterogeneity correction calculations is directly related to the choice of calculation algorithm. There are many calculation algorithms commercially available. They vary in accuracy and processing time. This study aimed to quantify the accuracy of ten different calculation algorithms in lung equivalent material and to analyze the impact of the algorithm choice in the dose distribution in Radiotherapy applied to lung tumors. METHODS: It was used plates of water (solid water RW3) and lung (cork) equivalent materials to determine the Percentage of Depth Dose (PDD) and transversal profile inside the heterogeneity (cork). The measurements were performed in a Clinac Varian 6EX, with 6 MV photon beams and two field sizes (5 x 5 cm2 and 10 x 10 cm2), through irradiation of radiochromic films Gafchromic EBT3 and ionization chamber Scanditronix Wellhofer CC13. Treatment planning of 25 patients - 11 with tridimensional (3D) technique and 14 with Stereotactic Body Radiation Therapy (SBRT) technique - were performed, first without heterogeneity correction and, by keeping the Monitor Units (MU), the calculations were then performed with the different algorithms/methods of heterogeneity corrections and the results were compared with the initial planning. It was analyzed the target volume and organs at risk doses. RESULTS: The measurements performed in phantoms revealed that algorithms based on the convolution principle (Eclipse® Pencil Beam Convolution with correction methods Batho, Batho Modified and Equivalent TAR; XiO® Clarkson and Convolution e iPlan® Pencil Beam) presented significant dose differences in the cork region, overestimating the measurement, with a overdose higher than 8%. More advanced algorithms, as Eclipse® AAA and Acuros XB, XiO® Superposition and iPlan® XVMC, presented deviations below to 3% in the heterogeneity region. The profile analysis showed, similarly, that the second class of algorithms presents better performance in medium with low electronic density, like cork. The penumbra width presented deviations below to 1 mm for the more sophisticated algorithms against differences up to 4.5 mm between the convolution based algorithms. The dose distribution analysis in lung treatment planning showed that all the calculations performed with heterogeneity corrections presented doses higher than the calculation without heterogeneity corrections. The target volume dose-volume histogram (DVH) had a higher impact compared to the organs at risk. The calculation performed with convolution based algorithms presented dose distributions comparable, although different from the calculation performed without heterogeneity correction. Eclipse® AAA, Acuros XB, XiO® Superposition and iPlan® XVMC presented dose distribution similar, however Eclipse® Acuros XB and iPlan® XVMC are still more similar. The SBRT treatment planning presented higher deviations from the calculation with no heterogeneity correction, compared with the 3D treatment planning. CONCLUSIONS: The different calculation algorithms available have different accuracies in low density mediums. These differences have impact in the dose distributions in lung treatment planning, being the impact higher for the SBRT technique. Between the evaluated algorithms there is, at least one of each manufacturer, that presented acceptable performance in lung equivalent material and it should be the choice in lung treatment planning calculation

Η στερεοτακτική μέθοδος ακτινοθεραπείας και ακτινοχειρουργικής είναι μια νεότερη μέθοδος της ογκολογίας, που αποδεδειγμένα υπερέχει έναντι της συμβατικής μεθόδου ακτινοβόλησης, ιδιαίτερα όταν συνδυάζεται με τελευταίες τεχνικές ακτινοβόλησης, όπως το IMRT, ArcTherapy and VMAT. Χαρακτηρίζεται δε από ακτινοβόληση με ιδιαίτερα υψηλές δόσεις, συνήθως πολύ μικρών όγκων, της τάξεως του εκατοστού. Εξαιτίας αυτών, είναι επιτακτική η ανάγκη για μέγιστη ακρίβεια και αποφυγή λαθών, καθώς δεν υπάρχουν περιθώρια σφάλματος! Κάθε ακτινοθεραπευτικό κέντρο οφείλει λοιπόν να ακολουθεί ένα ολοκληρωμένο και ιδιαίτερα αυστηρό πρόγραμμα ποιοτικού ελέγχου, θεσπίζοντας μια σειρά ελέγχων σε ημερήσια, εβδομαδιαία, μηνιαία και ετήσια βάση. Μέθοδος: Επειδή δεν υπάρχει ένα εντεταλμένο πρωτόκολλο Ποιοτικού Ελέγχου Στερεοτακτικής Ακτινοθεραπείας με Γραμμικό Επιταχυντή, αρχικά στην εργασία αυτή έγινε μια βιβλιογραφική μελέτη για να βρεθεί το state of the art αυτού του ζητήματος και να εντοπιστούν, σε πρώτη φάση, οι επιμέρους ποιοτικοί έλεγχοι που προτείνονται για τα διάφορα μέρη της στερεοτακτικής ακτινοβόλησης (εξοπλισμός και διαδικασία). Κατόπιν, προσδιορίστηκε μια συνολική, βέλτιστη και κατάλληλη για την πλειοψηφία των ακτινοθεραπευτικών κέντρων, λίστα ελέγχων για τη Διασφάλιση της Ποιότητας στην Στερεοτακτική Ακτινοθεραπεία. Αποτελέσματα: Ο Πίνακας των Ελέγχων που προέκυψε είναι – ως όφειλε – σύμφωνος με τα επιμέρους διεθνή πρωτόκολλα της Ευρώπης και Αμερικής. Βάσει αυτού προτείνεται ένα ολοκληρωμένο Πρόγραμμα Διασφάλισης Ποιότητας για Ακτινοθεραπευτικά Κέντρα που εφαρμόζουν στερεοταξία, το οποίο μπορεί να διαμορφωθεί από κάθε ακτινοθεραπευτικό κέντρο, βάσει των ιδιαιτεροτήτων αυτού, αλλά και να προσαρμοστεί σε μελλοντικές τεχνολογικές αλλαγές. Η εφαρμογή τέτοιων ελέγχων, τέλος, διερευνήθηκε στο ιδιωτικό θεραπευτήριο ΜΕΤΡΟΠΟΛΙΤΑΝ του Φαλήρου. Συμπεράσματα: Το πρόγραμμα ελέγχων που προτείνεται, αν και είναι σύμφωνο με τα επιμέρους διεθνή πρωτόκολλα ποιοτικού ελέγχου για τον εξοπλισμό και τη διαδικασία της ακτινοθεραπείας, πρέπει περαιτέρω να διερευνηθεί επί της κλινικής πράξης από ακτινοθεραπευτικά κέντρα, προκειμένου να βρεθούν τυχόν αδυναμίες και ελλείψεις και τελικώς να αποτελέσει τη βάση ενός μελλοντικού Πρωτόκολλου Διασφάλισης Ποιότητας Στερεοτακτικής Ακτινοθεραπείας με Γραμμικό Επιταχυντή, εγκεκριμένου από τους αρμόδιους διεθνείς φορείς και οργανισμούς. / Stereotactic Radiation Therapy (SRT) and Stereotactic RadioSurgery (SRS) are new advanced oncologic treatment modalities, which proved superior to the conventional method of irradiation, particularly when combined with latest irradiation techniques, such as IMRT, ArcTherapy and VMAT. They apply very high doses, to – usually – very small volumes (centimeters range). These characteristics mean great need for maximum accuracy and avoid mistakes, as there is no room for error! Therefore, every radiotherapy center must follow a very strict and comprehensive quality control program, adopting a series of checks on a daily, weekly, monthly and yearly basis. Method: Because there is no specific Quality Control Protocol for Stereotactic Radiotherapy using Linear Accelerator, the first part of this work was a literature study to find the state of the art of this issue and find, at first, the proposed quality controls for each part of stereotactic irradiation (equipment and process). Afterwards an overall checklist for Quality Assurance in Stereotactic Radiotherapy was defined, which was assessed as optimal and suitable for most radiotherapy centers. Results: The resulted table of checks is - as it should - in line with the different international protocols in Europe and America. Based on this, a comprehensive Quality Assurance Program for radiotherapy centers applying stereotaxis, is proposed. This may be configured and modified by each radiotherapy center, according to its specificities, and also adapt to future technological advances. Finally we look into the implementation of such controls, at the METROPOLITAN private hospital of Faliro. Conclusions: Although the recommended Control Program is consistent with the different international quality control protocols for the equipment and process of radiotherapy, the individual radiotherapy centers should further investigate this program when in clinical use, in order to find any deficiency or weakness. The ultimate goal was to create the basis for the future Quality Assurance Protocol in Stereotactic Radiotherapy with Linac, which should be approved by the competent international comities and organizations.

Introduction: The surgical and endovascular results of the treatment of pial AVM provided at our Neurosurgical centre are presented. These results are supported by neuropsychological outcomes of subgroup of treated patients. Going by these results and by an overview of literary data on the efficacy and complications of each therapeutic modality, the optimal algorithm of indications is presented Cohort of patients: The main series comprises 222 patients aged 9 to 87 years treated in the years 1998 - 2013. The surgical group consists of 85 patients, 55 patients received solely endovascular treatment. Thirty-four patients were consulted and referred directly to the Radiosurgical unit. The remaining 48 were recommended to abide by the strategy of "watch and wait". A subgroup of 66 patients, who underwent treatment of AVM was neuro-psychologically tested at least two years after treatment using a battery of tests constructed specifically for this study. A control group consisted of 10 subjects without any neurological disease. Results: In the surgical group, serious complications were 3.5% at a 96.5% therapeutic efficacy. As for AVM treated with purely endovascular methods, serious procedural complications were seen in 5.5% of patients, with efficacy totalling 36.4%. One observed patient suffered...

INTRODUÇÃO: Na Radioterapia, a acurácia da distribuição de dose em cálculos com correção de heterogeneidade está diretamente relacionada à escolha do algoritmo de cálculo. Existe uma variedade de algoritmos de cálculo disponíveis no mercado, variando em tempo de processamento e acurácia. Este estudo teve como objetivos quantificar a acurácia de dez diferentes algoritmos de cálculo em objetos simuladores de pulmão e analisar o impacto da escolha do algoritmo na distribuição de dose em radioterapia aplicada a tumores de pulmão. METODOLOGIA: Foram utilizados placas simuladoras de água (água sólida RW3) e pulmão (cortiça) para determinar a Porcentagem de Dose em Profundidade (PDP) e perfil transversal dentro da heterogeneidade (cortiça). As medidas foram realizadas em um Clinac Varian 6EX, com feixes de fótons de 6 MV e dois tamanhos de campo (5 x 5 cm2 e 10 x 10 cm2), irradiando-se filmes radiocrômicos Gafchromic EBT3 e câmara de ionização Scanditronix Wellhofer CC13. Planejamentos de 25 pacientes - 11 com técnica tridimendional (3D) e 14 com técnica de Radioterapia Estereotática Corpórea (SBRT) - foram realizados, inicialmente sem correção de heterogeneidade e, mantendo-se as UM, os cálculos com os diferentes algoritmos/métodos de correção foram comparados com o planejamento inicial. Foram avaliados as doses no volume alvo e nos órgãos em risco. RESULTADOS: As medidas realizadas em objetos simuladores revelaram que os algoritmos baseados no princípio da convolução (Eclipse® Pencil Beam Convolution com métodos de correção Batho, Batho Modificado e TAR equivalente; XiO® Clarkson e Convolution e iPlan® Pencil Beam) apresentaram diferenças de dose significativas na região da cortiça, sempre superestimando a medida, com uma sobredose superior a 8%. Algoritmos mais avançados, como o Eclipse® AAA e Acuros XB, XiO® Superposition e iPlan® XVMC, apresentaram desvios inferiores a 3% na região da heterogeneidade. A análise dos perfis mostra, igualmente, que a segunda classe de algoritmos apresenta melhor comportamento em meios de baixa densidade como a cortiça. A largura da penumbra apresentou desvios inferiores a 1 mm para os algoritmos mais avançados contra diferenças de até 4,5 mm entre os algoritmos baseados em convolução. A análise da distribuição de dose em planejamentos de tumores pulmonares mostrou que todos os cálculos com correção de heterogeneidade presentam doses superiores ao cálculo sem correção de heterogeneidade. O histograma dose-volume (DVH) do volume alvo sofreu um impacto maior do que dos órgãos em risco. Os cálculos realizados com algoritmos baseados em convolução apresentaram distribuições de dose semelhantes entre si, porém diferentes das do cálculo sem correção de heterogeneidade. Eclipse® AAA, Acuros XB, XiO® Superposition e iPlan® XVMC apresentaram distribuições de dose também semelhantes, porém Eclipse® Acuros XB e iPlan® XVMC são ainda mais similares. Os planejamentos de SBRT apresentaram resultados mais discrepantes do cálculo sem correção de heterogeneidade do que os planejamentos 3D. CONCLUSÕES: Os diferentes algoritmos de cálculo disponíveis possuem acurácias diferentes em meios de baixa densidade eletrônica. Essas diferenças possuem impacto nas distribuições de dose em planejamentos de tratamento de tumores pulmonares, sendo o impacto ainda maior para a técnica de SBRT. Entre os algoritmos avaliados, há pelo menos um de cada fabricante que apresentou bom desempenho em objetos simuladores de pulmão e que devem ser priorizados para o cálculo em planejamentos de tratamentos de câncer de pulmão / INTRODUCTION: In Radiotherapy, the dose distribution accuracy in heterogeneity correction calculations is directly related to the choice of calculation algorithm. There are many calculation algorithms commercially available. They vary in accuracy and processing time. This study aimed to quantify the accuracy of ten different calculation algorithms in lung equivalent material and to analyze the impact of the algorithm choice in the dose distribution in Radiotherapy applied to lung tumors. METHODS: It was used plates of water (solid water RW3) and lung (cork) equivalent materials to determine the Percentage of Depth Dose (PDD) and transversal profile inside the heterogeneity (cork). The measurements were performed in a Clinac Varian 6EX, with 6 MV photon beams and two field sizes (5 x 5 cm2 and 10 x 10 cm2), through irradiation of radiochromic films Gafchromic EBT3 and ionization chamber Scanditronix Wellhofer CC13. Treatment planning of 25 patients - 11 with tridimensional (3D) technique and 14 with Stereotactic Body Radiation Therapy (SBRT) technique - were performed, first without heterogeneity correction and, by keeping the Monitor Units (MU), the calculations were then performed with the different algorithms/methods of heterogeneity corrections and the results were compared with the initial planning. It was analyzed the target volume and organs at risk doses. RESULTS: The measurements performed in phantoms revealed that algorithms based on the convolution principle (Eclipse® Pencil Beam Convolution with correction methods Batho, Batho Modified and Equivalent TAR; XiO® Clarkson and Convolution e iPlan® Pencil Beam) presented significant dose differences in the cork region, overestimating the measurement, with a overdose higher than 8%. More advanced algorithms, as Eclipse® AAA and Acuros XB, XiO® Superposition and iPlan® XVMC, presented deviations below to 3% in the heterogeneity region. The profile analysis showed, similarly, that the second class of algorithms presents better performance in medium with low electronic density, like cork. The penumbra width presented deviations below to 1 mm for the more sophisticated algorithms against differences up to 4.5 mm between the convolution based algorithms. The dose distribution analysis in lung treatment planning showed that all the calculations performed with heterogeneity corrections presented doses higher than the calculation without heterogeneity corrections. The target volume dose-volume histogram (DVH) had a higher impact compared to the organs at risk. The calculation performed with convolution based algorithms presented dose distributions comparable, although different from the calculation performed without heterogeneity correction. Eclipse® AAA, Acuros XB, XiO® Superposition and iPlan® XVMC presented dose distribution similar, however Eclipse® Acuros XB and iPlan® XVMC are still more similar. The SBRT treatment planning presented higher deviations from the calculation with no heterogeneity correction, compared with the 3D treatment planning. CONCLUSIONS: The different calculation algorithms available have different accuracies in low density mediums. These differences have impact in the dose distributions in lung treatment planning, being the impact higher for the SBRT technique. Between the evaluated algorithms there is, at least one of each manufacturer, that presented acceptable performance in lung equivalent material and it should be the choice in lung treatment planning calculation

Introduction: The surgical and endovascular results of the treatment of pial AVM provided at our Neurosurgical centre are presented. These results are supported by neuropsychological outcomes of subgroup of treated patients. Going by these results and by an overview of literary data on the efficacy and complications of each therapeutic modality, the optimal algorithm of indications is presented Cohort of patients: The main series comprises 222 patients aged 9 to 87 years treated in the years 1998 - 2013. The surgical group consists of 85 patients, 55 patients received solely endovascular treatment. Thirty-four patients were consulted and referred directly to the Radiosurgical unit. The remaining 48 were recommended to abide by the strategy of "watch and wait". A subgroup of 66 patients, who underwent treatment of AVM was neuro-psychologically tested at least two years after treatment using a battery of tests constructed specifically for this study. A control group consisted of 10 subjects without any neurological disease. Results: In the surgical group, serious complications were 3.5% at a 96.5% therapeutic efficacy. As for AVM treated with purely endovascular methods, serious procedural complications were seen in 5.5% of patients, with efficacy totalling 36.4%. One observed patient suffered...